mRNA-1325

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-1325, covering 2024-06-17 to 2024-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects [Phase 1]